Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Stopped the research data is not statistically significant
Conditions
- Non-small Cell Lung Cancer Metastatic
- EGFR Activating Mutation
Interventions
- DRUG: Gefitinib
- DRUG: gemcitabine
- DRUG: carboplatin
Sponsor
Sichuan University
Collaborators